HeartFlow, Inc. (HTFL)
52.40
+0.45
(+0.87%)
USD |
NASDAQ |
Nov 06, 16:00
52.33
-0.07
(-0.13%)
After-Hours: 20:00
HeartFlow Enterprise Value : 4.409B for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 4.409B |
| November 05, 2026 | 4.370B |
| November 04, 2026 | 4.770B |
| November 03, 2026 | 4.582B |
| November 02, 2026 | 4.590B |
| October 30, 2026 | 4.985B |
| October 29, 2026 | 5.114B |
| October 28, 2026 | 4.990B |
| October 27, 2026 | 4.879B |
| October 26, 2026 | 4.808B |
| October 23, 2026 | 4.782B |
| October 22, 2026 | 4.671B |
| October 21, 2026 | 4.705B |
| October 20, 2026 | 4.685B |
| October 19, 2026 | 4.289B |
| October 16, 2026 | 4.052B |
| October 15, 2026 | 4.279B |
| October 14, 2026 | 4.154B |
| October 13, 2026 | 4.228B |
| October 12, 2026 | 4.249B |
| October 09, 2026 | 4.178B |
| October 08, 2026 | 3.995B |
| October 07, 2026 | 4.145B |
| October 06, 2026 | 4.260B |
| October 05, 2026 | 4.392B |
| Date | Value |
|---|---|
| October 02, 2026 | 4.141B |
| October 01, 2026 | 4.106B |
| September 30, 2026 | 4.179B |
| September 29, 2026 | 4.186B |
| September 28, 2026 | 4.194B |
| September 25, 2026 | 4.128B |
| September 24, 2026 | 4.084B |
| September 23, 2026 | 3.974B |
| September 22, 2026 | 4.215B |
| September 21, 2026 | 4.229B |
| September 18, 2026 | 4.265B |
| September 17, 2026 | 4.163B |
| September 16, 2026 | 4.053B |
| September 15, 2026 | 4.056B |
| September 14, 2026 | 4.161B |
| September 11, 2026 | 4.190B |
| September 10, 2026 | 3.809B |
| September 09, 2026 | 3.912B |
| September 08, 2026 | 4.005B |
| September 04, 2026 | 4.106B |
| September 03, 2026 | 4.175B |
| September 02, 2026 | 4.200B |
| September 01, 2026 | 4.238B |
| August 31, 2026 | 4.234B |
| August 28, 2026 | 4.008B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biotricity, Inc. | 31.74M |
| Aclarion, Inc. | -9.426M |
| Retrieve Medical Holdings, Inc. | 19.78M |
| Iovance Biotherapeutics, Inc. | 3.388B |
| The Cooper Cos., Inc. | 14.24B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.74M |
| Revenue (Quarterly) | 64.08M |
| Total Expenses (Quarterly) | 79.82M |
| EPS Diluted (Quarterly) | -0.1822 |
| Gross Profit Margin (Quarterly) | 83.00% |
| Profit Margin (Quarterly) | -24.57% |
| Earnings Yield | -2.67% |
| Normalized Earnings Yield | -1.865 |